|
Volumn 11, Issue 1, 2004, Pages 61-69
|
Novel antiarrhythmic compounds with combined class IB and class III mode of action
|
Author keywords
Class I B; Class III antiarrhythmics; Dual mode of action; GYKI 16638; N (phenylalkyl) N (phenoxyalkyl)amines
|
Indexed keywords
ALIPHATIC AMINE;
AMBASILIDE;
AMIODARONE;
ANTIARRHYTHMIC AGENT;
CIBENZOLINE;
DISOPYRAMIDE;
DOFETILIDE;
ENCAINIDE;
FLECAINIDE;
GYKI 16638;
MEXILETINE;
POTASSIUM CHANNEL BLOCKING AGENT;
PROPAFENONE;
PYRIDAZINONE DERIVATIVE;
SODIUM CHANNEL BLOCKING AGENT;
SOTALOL;
TOCAINIDE;
UNCLASSIFIED DRUG;
ANTIARRHYTHMIC ACTIVITY;
CARDIOVASCULAR DISEASE;
CONTROLLED STUDY;
DOG;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG USE;
HEART ARRHYTHMIA;
HEART DEPOLARIZATION;
HEART MUSCLE CONDUCTION DISTURBANCE;
HUMAN;
IN VIVO STUDY;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MORTALITY;
NONHUMAN;
RABBIT;
REVIEW;
STRUCTURE ACTIVITY RELATION;
TORSADE DES POINTES;
ACTION POTENTIALS;
ANIMALS;
ANTI-ARRHYTHMIA AGENTS;
CORONARY DISEASE;
DELAYED RECTIFIER POTASSIUM CHANNELS;
DRUG DESIGN;
HEART CONDUCTION SYSTEM;
HEART VENTRICLES;
MEXILETINE;
PAPILLARY MUSCLES;
PHENETHYLAMINES;
POTASSIUM CHANNELS;
POTASSIUM CHANNELS, VOLTAGE-GATED;
SOTALOL;
SULFONAMIDES;
|
EID: 9144220806
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867043456232 Document Type: Review |
Times cited : (19)
|
References (25)
|